Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Expression of the target receptor CD33 in CD34+/CD38−/CD123+ AML stem cells

Hauswirth, A.W., Florian, S., Printz, D., Sotlar, K., Krauth, M.‐T., Fritsch, G., Schernthaner, G.‐H., Wacheck, V., Selzer, E., Sperr, W.R., Valent, P.·2007·European Journal of Clinical Investigation

Abstract

Background CD33 (Siglec‐3) is becoming increasingly important as a target of antibody‐mediated therapy in acute myeloid leukaemia (AML). In normal myelopoiesis, expression of CD33 is restricted to advanced stages of differentiation, whereas primitive stem cells do not express CD33. In the present study, we asked whether leukaemic stem cells in patients with AML express CD33. Materials and methods A multicolour‐staining technique was applied in 11 patients with AML, and leukaemic progenitors defined as CD34+/CD38−/CD123+ cells. AML stem cells were purified by cell sorting and were examined for expression of CD33 mRNA by reverse transcriptase–polymerase chain reaction (RT–PCR). Results In all patients in whom the majority of myeloblasts expressed CD33 (n = 8), AML progenitors reacted with the CD33 antibody P67·6. Repopulation experiments utilizing irradiated NOD/SCID mice confirmed that AML stem cells in these patients reside within the CD33+ subpopulation of the leukaemic clone. Moreover, highly purified AML stem cells (> 98% purity) from patients with CD33+ AML were found to express CD33 mRNA in RT–PCR analyses. CD33 was neither detectable on CD34+/CD38− cells in normal bone marrow nor on leukaemic stem cells in patients with CD33‐negative AML. Conclusions Leukaemic stem cells in patients with CD33+ AML express CD33. This observation is in favour of novel treatment concepts employing CD33‐targeting antibodies in AML.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2362.2007.01746.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 158

Metadata

Authors
Hauswirth, A. W., Florian, S., Printz, D., Sotlar, K., Krauth, M. ‐., Fritsch, G., Schernthaner, G. ‐., Wacheck, V., Selzer, E., Sperr, W. R., & Valent, P.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
2006-12-06
Volume
37
Issue
1
Pages
73-82
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W1990564763
Cited by
158
References
2
FWCI
3.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expression of the target receptor CD33 in CD34+/CD38−/CD123+ AML stem cells. https://app.cochat.ai/papers/10.1111/j.1365-2362.2007.01746.x
The paper
Hauswirth, A. W., Florian, S., Printz, D., Sotlar, K., Krauth, M. ‐., Fritsch, G., Schernthaner, G. ‐., Wacheck, V., Selzer, E., Sperr, W. R., & Valent, P. (2007). Expression of the target receptor CD33 in CD34+/CD38−/CD123+ AML stem cells. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2007.01746.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.